These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 22326466

  • 1. The therapeutic effect of histone deacetylase inhibitor PCI-24781 on gallbladder carcinoma in BK5.erbB2 mice.
    Kitamura T, Connolly K, Ruffino L, Ajiki T, Lueckgen A, DiGiovanni J, Kiguchi K.
    J Hepatol; 2012 Jul; 57(1):84-91. PubMed ID: 22326466
    [Abstract] [Full Text] [Related]

  • 2. Interaction of Muc4 and ErbB2 in a transgenic mouse model of gallbladder carcinoma: potential pathobiological implications.
    Miyahara N, Shoda J, Kawamoto T, Ishida H, Ueda T, Akimoto Y, Kawakami H, Irimura T.
    Oncol Rep; 2014 Nov; 32(5):1796-802. PubMed ID: 25174601
    [Abstract] [Full Text] [Related]

  • 3. Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas.
    Pignochino Y, Sarotto I, Peraldo-Neia C, Penachioni JY, Cavalloni G, Migliardi G, Casorzo L, Chiorino G, Risio M, Bardelli A, Aglietta M, Leone F.
    BMC Cancer; 2010 Nov 18; 10():631. PubMed ID: 21087480
    [Abstract] [Full Text] [Related]

  • 4. Chemopreventive and therapeutic efficacy of orally active tyrosine kinase inhibitors in a transgenic mouse model of gallbladder carcinoma.
    Kiguchi K, Ruffino L, Kawamoto T, Ajiki T, Digiovanni J.
    Clin Cancer Res; 2005 Aug 01; 11(15):5572-80. PubMed ID: 16061875
    [Abstract] [Full Text] [Related]

  • 5. A novel HDAC inhibitor, CG200745, inhibits pancreatic cancer cell growth and overcomes gemcitabine resistance.
    Lee HS, Park SB, Kim SA, Kwon SK, Cha H, Lee DY, Ro S, Cho JM, Song SY.
    Sci Rep; 2017 Jan 30; 7():41615. PubMed ID: 28134290
    [Abstract] [Full Text] [Related]

  • 6. The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces growth inhibition and enhances gemcitabine-induced cell death in pancreatic cancer.
    Arnold NB, Arkus N, Gunn J, Korc M.
    Clin Cancer Res; 2007 Jan 01; 13(1):18-26. PubMed ID: 17200334
    [Abstract] [Full Text] [Related]

  • 7. Combined targeting of histone deacetylases and hedgehog signaling enhances cytoxicity in pancreatic cancer.
    Chun SG, Zhou W, Yee NS.
    Cancer Biol Ther; 2009 Jul 01; 8(14):1328-39. PubMed ID: 19421011
    [Abstract] [Full Text] [Related]

  • 8. Suberoylanilide hydroxamic acid combined with gemcitabine enhances apoptosis in non-small cell lung cancer.
    Rundall BK, Denlinger CE, Jones DR.
    Surgery; 2005 Aug 01; 138(2):360-7. PubMed ID: 16153448
    [Abstract] [Full Text] [Related]

  • 9. Bile acid accelerates erbB2-induced pro-tumorigenic activities in biliary tract cancer.
    Kitamura T, Srivastava J, DiGiovanni J, Kiguchi K.
    Mol Carcinog; 2015 Jun 01; 54(6):459-72. PubMed ID: 24839254
    [Abstract] [Full Text] [Related]

  • 10. Apicidin sensitizes pancreatic cancer cells to gemcitabine by epigenetically regulating MUC4 expression.
    Ansari D, Urey C, Hilmersson KS, Bauden MP, Ek F, Olsson R, Andersson R.
    Anticancer Res; 2014 Oct 01; 34(10):5269-76. PubMed ID: 25275019
    [Abstract] [Full Text] [Related]

  • 11. Histone deacetylase inhibitor (SAHA) and repression of EZH2 synergistically inhibit proliferation of gallbladder carcinoma.
    Yamaguchi J, Sasaki M, Sato Y, Itatsu K, Harada K, Zen Y, Ikeda H, Nimura Y, Nagino M, Nakanuma Y.
    Cancer Sci; 2010 Feb 01; 101(2):355-62. PubMed ID: 19860841
    [Abstract] [Full Text] [Related]

  • 12. Gemcitabine resistant pancreatic cancer cell lines acquire an invasive phenotype with collateral hypersensitivity to histone deacetylase inhibitors.
    Samulitis BK, Pond KW, Pond E, Cress AE, Patel H, Wisner L, Patel C, Dorr RT, Landowski TH.
    Cancer Biol Ther; 2015 Feb 01; 16(1):43-51. PubMed ID: 25485960
    [Abstract] [Full Text] [Related]

  • 13. RuvBL2 is involved in histone deacetylase inhibitor PCI-24781-induced cell death in SK-N-DZ neuroblastoma cells.
    Zhan Q, Tsai S, Lu Y, Wang C, Kwan Y, Ngai S.
    PLoS One; 2013 Feb 01; 8(8):e71663. PubMed ID: 23977108
    [Abstract] [Full Text] [Related]

  • 14. Histone Deacetylase Inhibitors Inhibit the Proliferation of Gallbladder Carcinoma Cells by Suppressing AKT/mTOR Signaling.
    Zhang P, Guo Z, Wu Y, Hu R, Du J, He X, Jiao X, Zhu X.
    PLoS One; 2015 Feb 01; 10(8):e0136193. PubMed ID: 26287365
    [Abstract] [Full Text] [Related]

  • 15. Decitabine and suberoylanilide hydroxamic acid (SAHA) inhibit growth of ovarian cancer cell lines and xenografts while inducing expression of imprinted tumor suppressor genes, apoptosis, G2/M arrest, and autophagy.
    Chen MY, Liao WS, Lu Z, Bornmann WG, Hennessey V, Washington MN, Rosner GL, Yu Y, Ahmed AA, Bast RC.
    Cancer; 2011 Oct 01; 117(19):4424-38. PubMed ID: 21491416
    [Abstract] [Full Text] [Related]

  • 16. Functional cooperation of miR-125a, miR-125b, and miR-205 in entinostat-induced downregulation of erbB2/erbB3 and apoptosis in breast cancer cells.
    Wang S, Huang J, Lyu H, Lee CK, Tan J, Wang J, Liu B.
    Cell Death Dis; 2013 Mar 21; 4(3):e556. PubMed ID: 23519125
    [Abstract] [Full Text] [Related]

  • 17. Combination chemotherapy of nafamostat mesylate with gemcitabine for gallbladder cancer targeting nuclear factor-κB activation.
    Iwase R, Haruki K, Fujiwara Y, Furukawa K, Shiba H, Uwagawa T, Misawa T, Ohashi T, Yanaga K.
    J Surg Res; 2013 Sep 21; 184(1):605-12. PubMed ID: 23830367
    [Abstract] [Full Text] [Related]

  • 18. Synergistic antineoplastic effect of DLC1 tumor suppressor protein and histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), on prostate and liver cancer cells: perspectives for therapeutics.
    Zhou X, Yang XY, Popescu NC.
    Int J Oncol; 2010 Apr 21; 36(4):999-1005. PubMed ID: 20198346
    [Abstract] [Full Text] [Related]

  • 19. Effect of histone deacetylase inhibitor on proliferation of biliary tract cancer cell lines.
    Xu LN, Wang X, Zou SQ.
    World J Gastroenterol; 2008 Apr 28; 14(16):2578-81. PubMed ID: 18442209
    [Abstract] [Full Text] [Related]

  • 20. Induction of caspase mediated apoptosis and down-regulation of nuclear factor-κB and Akt signaling are involved in the synergistic antitumor effect of gemcitabine and the histone deacetylase inhibitor trichostatin A in human bladder cancer cells.
    Jeon HG, Yoon CY, Yu JH, Park MJ, Lee JE, Jeong SJ, Hong SK, Byun SS, Lee SE.
    J Urol; 2011 Nov 28; 186(5):2084-93. PubMed ID: 21944112
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.